There is a growing demand for oligonucleotides as medicaments and other uses due to their broad spectrum.
Technology at the service of Health
Our innovative science
Since our founding in 2006, we have pioneered RNAi-based medicines through R&D efforts that have led to fundamental advances and innovations that make RNAi therapies possible.
We have scientific expertise after more than 15 years working on RNAi-based therapies through our precision-engineered medicines to drive positive change in the treatment of disease.
At the forefront of innovation
We apply the most innovative scientific tools, such as artificial intelligence, to the development of a new generation of medicines that potentially allow us to address the needs of patients who have limited or inadequate treatment options. We have established a robust and versatile platform for RNAi-based drug discovery, SirFINDER, which allows us to develop effective therapies quickly, cost-effectively and potentially with lower risk relative to traditional approaches.
Our interdisciplinary team works tirelessly to make one goal a reality: improving the health of patients through cutting-edge science. Our culture reflects our company spirit: scientific excellence, hard work, creativity and diversity. We are committed to organizational flexibility and the disappearance of barriers in the company. In addition, we have a network of collaborators with research centers, national and international universities and public or private centers for our developments.
Through science and innovative medicine, Sylentis intends to become one of the main companies specialized in the discovery, development and manufacture of products based on RNAi technology for the treatment of diseases with great social impact.
Our ambition is to become the company in the sector that is most highly valued by patients, healthcare professionals, collaborators, institutional and community representatives. At Sylentis, we aspire to increase our competitiveness as a pharmaceutical company by promoting the therapeutic areas in which we research and develop medicines. Our goal is to ensure our responsiveness to unmet needs in the treatment of the disease.
Commitment to innovation
We apply our talent, knowledge and resources to produce new ideas.
The team as the source of our strength
Our company is strong because of our different, participative and properly trained employees.
We strive for growth, transformation and renewal. We are creative and constructive as a source of inspiration and vitality.
Commitment to our stakeholders
We measure our success by the ability to get people to achieve their goals and develop. Patients, physicians, shareholders, employees and customers deserve our best efforts.